ABSTRACT
Background Reliable tools to inform outpatient management of childhood pneumonia in resource-limited settings are needed. We investigated the value added by biomarkers of host infection response to the performance of the Liverpool quick Sequential Organ Failure Assessment score (LqSOFA), for triage of children presenting with pneumonia to a primary care clinic in a refugee camp on the Thailand-Myanmar border.
Methods 900 presentations of children aged ≤ 24 months meeting WHO pneumonia criteria were included. The primary outcome was receipt of supplemental oxygen. We compared discrimination of a clinical risk score (LqSOFA) to markers of endothelial injury (Ang-1, Ang-2, sFlt-1), immune activation (CHI3L1, IP-10, IL-1ra, IL-6, IL-8, IL-10, sTNFR-1, sTREM-1), and inflammation (CRP, PCT), and quantified the net-benefit of including biomarkers alongside LqSOFA. We evaluated the differential contribution of LqSOFA and host biomarkers to the diagnosis and prognosis of severe pneumonia.
Results 49/900 (5.4%) presentations met the primary outcome. Discrimination of LqSOFA and Ang-2, the best performing biomarker, were comparable (AUC 0.82 [95% CI 0.76-0.88] and 0.81 [95% CI 0.74-0.87] respectively). Combining Ang-2 with LqSOFA improved discrimination (AUC 0.91; 95% CI 0.87-0.94; p < 0.001), and resulted in greater net-benefit, with 10-30% fewer children requiring oxygen supplementation incorrectly identified as safe for community-based management. Ang-2 had greater prognostic utility than LqSOFA to identify children requiring supplemental oxygen later in their illness course.
Conclusions Combining Ang-2 and LqSOFA could guide referrals of childhood pneumonia from resource-limited community settings. Further work on integration into patient triage is required.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded by the UK Wellcome Trust [219644/Z/19/Z]. RPS acknowledges part support from the NIHR Applied Research Collaboration Oxford & Thames Valley, the NIHR Oxford Medtech and In-Vitro Diagnostics Co-operative and the Oxford Martin School. CK is supported by a Wellcome Trust/Royal Society Sir Henry Dale Fellowship [211182/Z/18/Z]. For the purpose of open access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approvals were provided by the Mahidol University Ethics Committee (TMEC 21-023) and Oxford Tropical Research Ethics Committee (OxTREC 511-21).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
De-identified, individual participant data from this study will be available to researchers whose proposed purpose of use is approved by the data access committees at the Mahidol-Oxford Tropical Medicine Research Unit. Inquiries or requests for the data may be sent to datasharing{at}tropmedres.ac.
ABBREVIATIONS
- ANG-1
- angiopoietin-1
- ANG-2
- angiopoietin-2
- ARI
- acute respiratory infection
- AUC
- area under the receiver operating characteristic curve
- AVPU
- Alert Voice Pain Unresponsive
- CHI3L1
- chitinase-3-like protein-1
- CI
- confidence interval
- CRP
- C-reactive protein
- IL-1ra
- interleukin-1 receptor antagonist
- IL-6
- interleukin-6
- IL-8
- interleukin-8
- IL-10
- interleukin-10
- IP-10
- inducible protein-10 [CXCL-10]
- IQR
- interquartile range
- LAZ
- length-for-age z-score
- LMIC
- low- and middle-income country
- LOQ
- limit of quantification
- LqSOFA
- Liverpool quick Sequential Organ Failure Assessment
- MAZ
- MUAC-for-age z-score
- MUAC
- mid-upper arm circumference
- NLR
- negative likelihood ratio
- OxTREC
- Oxford Tropical Research Ethics Committee
- PCT
- procalcitonin
- PLR
- positive likelihood ratio
- qSOFA
- quick Sequential Organ Failure Assessment
- sFlt-1
- soluble fms-like tyrosine kinase-1 [sVEGFR-1]
- SpO2
- 75 peripheral oxygen saturation
- sTNFR-1
- soluble tumour necrosis factor receptor-1
- sTREM-1
- soluble triggering receptor expressed on myeloid cells-1
- STROBE
- Strengthening the Reporting of Observational Studies in Epidemiology
- TMEC
- Tropical Medicine Ethics Committee
- USA
- United States of America
- WAZ
- weight-for-age z-score
- WLZ
- weight-for-length z-score
- WHO
- World Health Organization
